$10.46
-2.8%Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Chief Human Resources Officer & Executive Vice President
EVP and Chief Brand & Digital Officer
Executive Vice President & Chief Commercial Officer
Compensation
$988,533
Executive Vice President & Chief Financial Officer
Compensation
$1,127,571
Executive Vice President & Chief Scientific Officer
Compensation
$1,694,913
Executive Vice President of Product Supply, Operations Strategy & Transformation Officer
Executive Vice President, General Counsel & Secretary
Compensation
$1,048,300
President, Chief Executive Officer & Director
Compensation
$2,052,039
Senior VP & Treasurer
Vice President of Global Investor Relations
Vice President of Global Investor Relations & Corporate Communications
During the last 12 months, insiders have purchased $464K worth of PRGO shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
8.8K
134.47K
0
0.00
+134K
+$134K
14.3K
329.46K
0
0.00
+329K
+$329K
Parker Geoffrey M.
Director
$307K
Bezerra Eduardo Guarita
Officer: Evp & Chief Financial Officer
$68K
Willis Robert
Officer: Evp & Chro
$36K
Lennox Abigail
Officer: Evp And Cso
$28K
Atkinson Charles
Officer: Evp, General Counsel & Sec.
$23K
No selling activity
Strong bullish signal with $464K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
PRGO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 20, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 21, 2025 | May 01, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 22, 2024 | May 02, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 24, 2023 | March 24, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 24, 2022 | May 06, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 01, 2021 | May 12, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 27, 2020 | May 06, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 14, 2019 | April 26, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 23, 2018 | May 04, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | June 07, 2017 | July 20, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.